These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 20369732)
1. [The structure and role of CR1 complement receptor in physiology]. Rochowiak A; Niemir ZI Pol Merkur Lekarski; 2010 Jan; 28(163):79-83. PubMed ID: 20369732 [TBL] [Abstract][Full Text] [Related]
2. [The role of CR1 complement receptor in pathology]. Rochowiak A; Niemir ZI Pol Merkur Lekarski; 2010 Jan; 28(163):84-8. PubMed ID: 20369733 [TBL] [Abstract][Full Text] [Related]
3. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects. Katyal M; Tiwari SC; Kumar A; Dinda AK; Arora V; Kumar R; Das N Mol Immunol; 2004 Apr; 40(18):1325-32. PubMed ID: 15072851 [TBL] [Abstract][Full Text] [Related]
4. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway. Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013 [TBL] [Abstract][Full Text] [Related]
5. The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35). Liu D; Niu ZX Immunopharmacol Immunotoxicol; 2009; 31(4):524-35. PubMed ID: 19874218 [TBL] [Abstract][Full Text] [Related]
6. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation. Mossakowska D; Dodd I; Pindar W; Smith RA Eur J Immunol; 1999 Jun; 29(6):1955-65. PubMed ID: 10382758 [TBL] [Abstract][Full Text] [Related]
8. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor. Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408 [TBL] [Abstract][Full Text] [Related]
9. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement. Makrides SC; Scesney SM; Ford PJ; Evans KS; Carson GR; Marsh HC J Biol Chem; 1992 Dec; 267(34):24754-61. PubMed ID: 1447213 [TBL] [Abstract][Full Text] [Related]
11. Primary sequence of an alternatively spliced form of CR1. Candidate for the 75,000 M(r) complement receptor expressed on chimpanzee erythrocytes. Birmingham DJ; Shen XP; Hourcade D; Nickells MW; Atkinson JP J Immunol; 1994 Jul; 153(2):691-700. PubMed ID: 8021505 [TBL] [Abstract][Full Text] [Related]
12. The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood. Nielsen CH; Antonsen S; Matthiesen SH; Leslie RG Eur J Immunol; 1997 Nov; 27(11):2914-9. PubMed ID: 9394818 [TBL] [Abstract][Full Text] [Related]
13. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. Molina H; Kinoshita T; Webster CB; Holers VM J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513 [TBL] [Abstract][Full Text] [Related]
14. Analysis of complement receptor type 1 expression on red blood cells in negative phenotypes of the Knops blood group system, according to CR1 gene allotype polymorphisms. Pham BN; Kisserli A; Donvito B; Duret V; Reveil B; Tabary T; Le Pennec PY; Peyrard T; Rouger P; Cohen JH Transfusion; 2010 Jul; 50(7):1435-43. PubMed ID: 20210926 [TBL] [Abstract][Full Text] [Related]
15. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Danielsson C; Pascual M; French L; Steiger G; Schifferli JA Eur J Immunol; 1994 Nov; 24(11):2725-31. PubMed ID: 7957565 [TBL] [Abstract][Full Text] [Related]
16. Identification of complement receptor one (CR1) polymorphisms in west Africa. Moulds JM; Kassambara L; Middleton JJ; Baby M; Sagara I; Guindo A; Coulibaly S; Yalcouye D; Diallo DA; Miller L; Doumbo O Genes Immun; 2000 Jun; 1(5):325-9. PubMed ID: 11196694 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. Yoon SH; Fearon DT J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931 [TBL] [Abstract][Full Text] [Related]
18. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor. Subramanian VB; Clemenza L; Krych M; Atkinson JP J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632 [TBL] [Abstract][Full Text] [Related]